✦ LIBER ✦

A placebo-controlled, dose-ranging study of montelukast, a cysteinyl leukotriene–receptor antagonist

✍ Scribed by Altman, Leonard C.; Munk, Zev; Seltzer, James; Noonan, Nancy; Shingo, Sumiko; Zhang, Ji; Reiss, Theodore F.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Biological effects of montelukast, a cys

✍ F. Spinozzi; A. M. Russano; S. Piattoni; E. Agea; O. Bistoni; D. De Benedictis; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 249 KB

Efficacy of montelukast, a leukotriene r

✍ Hiroyuki Fujiwara; Ryo Konno; Sachiho Netsu; Kohei Odagiri; Akiyo Taneichi; Sato 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 236 KB

Montelukast, a Cysteinyl Leukotriene Rec

✍ Yu, Guo-Liang; Wei, Er-Qing; Zhang, Shi-Hong; Xu, Hui-Ming; Chu, Li-Sheng; Zhang 📂 Article 📅 2004 🏛 S. Karger AG 🌐 English ⚖ 386 KB

Pathophysiological role of mast cells in

✍ Naotaka Shiota; Keiko Shimoura; Hideki Okunishi 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 472 KB

The leukotriene receptor antagonist mont

✍ Erbagci, Zülal 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 114 KB

Renoprotective effects of montelukast, a

✍ Abdel-Raheem, Ihab T.; Khedr, Naglaa F. 📂 Article 📅 2013 🏛 Springer-Verlag 🌐 English ⚖ 882 KB